- Washington, District of Columbia
Available for $495.00
Discover Why Hundreds of Legal and Compliance Executives and Dozens of Industry-Respected CCOs Attend CBI’s Esteemed Compliance Congress Each Year…
Why PCC? As the government continues to pursue investigations and announce large-dollar settlements for healthcare fraud enforcement, compliance professionals are continually working to better their internal processes, oversight and strategy to propel corporate compliance programs forward and instill a culture of ethics and integrity across the organization. Best practices are ever-evolving and CBI is pleased to organize the industry’s preferred educational sessions and unique networking opportunities that unite senior-level executives to share innovative efforts, lessons learned and compliance successes.
PCC 2013 Delivers…
Leadership from Congress Co-Chairs: Kris Curry, Vice President, Health Care Compliance, Pharmaceuticals Group, Johnson & Johnson and Cynthia "Cindy" Cetani, Vice President, Ethics & Compliance and Chief Compliance Officer, Novartis Pharmaceuticals Corporation
Keynote Addresses from: U.S. Attorneys and the DOJ, FDA Office of Chief Counsel and OPDP, CMS, APCR, PhRMA and a Special Post-Election Update on “The Next 4 Years – What to Expect from Congress, the States, FDA and CMS”
An executive-level industry speaking faculty, including representation from Auxilium, Biogen Idec, Boehringer Ingelheim, BTG, Celgene, Dendreon, Eisai, Fresenius Kabi, Incyte, Ipsen, Meda, Medicis, Par, Purdue, Pfizer, Purdue, Quintiles, Sunovion, Takeda, Teva, UCB and Vertex
A robust agenda covering all aspects of regulatory, commercial, clinical and corporate compliance program management
Interactive formatting affording attendees the opportunity to develop their own conference agenda from 45 different educational sessions for the ability to share and learn directly with peers in focused settings
Tracked programming and workshops featuring hot topics and responsibilities including: Sunshine and Global HCP Aggregate Spend Reporting, Promotional Compliance and Off-Label Controls, Clinical Research and Pre-Approval Communications, Global ABAC and International Compliance, Effective Training, Monitoring Commercial Risk, Conducting Investigations, CIA Readiness, Government Pricing, Compliance Program Effectiveness and much more
The exclusive, closed-door CCO Summit for those with the top responsibility for compliance at their companies
CLE, CPE and for the first time, SCCE credits (pending approval)
The industry unites in January – Be a part of the dialogue!
